mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |